|
Index of reports
> Cases resulting in hospitalization (99)
> Cases with Convulsion (8)
Below is the selection of adverse event reports related to Topamax (Topiramate) that includes cases resulting in hospitalization where reactions include convulsion.
Adverse event in 12 year old male receiving Topamax (Topiramate)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-09
Patient: 12 year old male, weighing 22.0 kg (48.4 pounds)
Adverse reactions / side effects: Renal Disorder, Blood Electrolytes Abnormal, Condition Aggravated, Pyrexia, Hypercalcaemia, Convulsion, Urine Electrolytes Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Elaprase (Idursulfase) Concentrate FOR Infusion
Dosage: 12 mg, 1x/week, iv drip
Indication: Mucopolysaccharidosis II
Start date: 2007-01-01
Topamax
Other drugs received by patient: Klonopin; Atrovent; Miralax
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-07-24
Patient: female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Body Height Decreased, Cheilitis, Complex Regional Pain Syndrome, Muscular Weakness, Chronic Obstructive Pulmonary Disease, Convulsion, Cystitis Interstitial
Adverse event resulted in: hospitalization
Suspect drug(s):
Duragesic-100
Indication: Complex Regional Pain Syndrome
Topamax
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Nexium; Hydromorphone HCL; Zoloft; Alprazolam; Temazepam
Adverse event in female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-06-21
Patient: female
Adverse reactions / side effects: Agitation, Ocular Hyperaemia, Platelet Count Decreased, Status Epilepticus, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Depakote; Nortrel 7 / 7 / 7; Phenobarbital TAB
Adverse event in 44 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from Canada on 2007-05-11
Patient: 44 year old female, weighing 42.6 kg (93.8 pounds)
Adverse reactions / side effects: Choking Sensation, Weight Decreased, Nasopharyngitis, Therapeutic Response Unexpected, Herpes Zoster, Pharyngeal Oedema, Skin Discolouration, Chest Pain, Dizziness, Palmar Erythema, Gastrooesophageal Reflux Disease, Muscle Spasms, RIB Fracture, Swelling Face, Chest Discomfort, Dyspnoea, Pain in Extremity, Muscular Weakness, Hypoaesthesia, Swollen Tongue, Musculoskeletal Chest Pain, Convulsion, Tremor, Anxiety, Burning Sensation, Throat Irritation, Sensory Disturbance, Depressed Level of Consciousness, Cardiovascular Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Topamax
Indication: Pain Management
Ciprofloxacin
Indication: Drug USE FOR Unknown Indication
Forteo
Indication: Osteoporosis
Other drugs received by patient: Demerol; Tylenol; Ogen; Calcium Chloride; Vitamin D; Vitamin B-12; Miacalcin
Adverse event in 3 year old male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-07
Patient: 3 year old male
Adverse reactions / side effects: Blood Glucose Decreased, Nuclear Magnetic Resonance Imaging Abnormal, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Claritin
Dosage: 5 ml;once;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-03-29
End date: 2007-03-29
Triaminic SRT
Dosage: 1 df;q6h;po
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2006-11-01
End date: 2007-03-29
Robitussin / 00048001 /
Dosage: 5 ml;once;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-03-29
End date: 2007-03-29
Topamax
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 37 year old male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-03-12
Patient: 37 year old male, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Autonomic Nervous System Imbalance, Cognitive Disorder, Amnesia, Aggression, Convulsion, Mental Impairment, Burning Sensation, Overdose, Sleep Disorder
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Topamax
Dosage: 100 mg 1- bedtime 1st week; 2 x -2nd week; 3x day 3rd week
Start date: 2002-01-31
Topamax
Dosage: 100 mg 1- bedtime 1st week; 2 x -2nd week; 3x day 3rd week
Start date: 2002-02-13
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-02-01
Patient: male, weighing 40.8 kg (89.8 pounds)
Adverse reactions / side effects: Accident, Diarrhoea, Pancreatitis, Convulsion, Gastroenteritis Viral
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Lamictal; Ativan; Dyastat; Clorasap
Adverse event in male receiving Topamax (Topiramate)
Reported by a physician from Germany on 2007-01-11
Patient: male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Mantle Cell Lymphoma Stage III, Status Epilepticus, Convulsion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Topamax
Dosage: 100 - 0 - 50 mg
Administration route: Oral
Start date: 2003-02-01
Topamax
Administration route: Oral
Indication: Epilepsy
Start date: 2003-02-01
Other drugs received by patient: Tegretol; Tegretol; Carbamazepin Retard; Carbamazepin Retard; Carbamazepin Retard
|
